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Abstract 
The historical roots of the stem cell concept are traced with respect to its usage in embryology and 
in hematology. The modern consensus definition of stem cells, comprising both pluripotent stem 
cells in culture and tissue-specific stem cells in vivo, is explained and explored. Methods for 
identifying stem cells are discussed with respect to cell surface markers, telomerase, label retention 
and transplantability, and properties of the stem cell niche are explored. The CreER method for 
identifying stem cells in vivo is explained, as is evidence in favor of a stochastic rather than an 
obligate asymmetric form of cell division. In conclusion it is found that stem cells do not possess any 
unique and specific molecular markers; and stem cell behavior depends on the environment of the 
cell as well as the stem cell's intrinsic qualities. Furthermore the stochastic mode of division implies 
that stem cell behavior is a property of a cell population not of an individual cell. In this sense, stem 
cells do not exist in isolation but only as a part of multicellular system. 
NOTE: Although this is a new article, some sections of text and some figures have been taken from 
chapter 1 of "The Science of Stem Cells" by J.M.W.Slack; Wiley (2018). These are reproduced by 
permission of John Wiley & Sons Inc. 
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Introduction 
Interest in stem cells continues to accelerate, as may be seen from the exponential increase in 
the number of papers on the topic over the last four decades (Fig.1).  Because of this rise in interest, 
many biomedical scientists have felt that their chances of funding would be improved if they were 
seen to be working on stem cells, and this has led to the dilution of what is meant by the term "stem 
cell" to a level that becomes unhelpful. Sometimes virtually any cell that divides is called a stem cell. 
Of course the meaning of a term depends on how it is defined and if all cells that divide are to be 
called stem cells then this might be considered a legitimate usage. However definitions cease to be 
useful if they become all-embracing. To remain useful they need to accord with reality as much as 
possible, or, as philosophers say, correspond to a "natural kind" 1.  
There are two natural kinds of stem cell: the pluripotent stem cell growing in culture, 
otherwise known as embryonic stem cells (ESC) or induced pluripotent stem cells (iPSC); and the 
tissue-specific stem cells which maintain the turnover of certain tissue types in mammals and other 
animals. Each of these has its own historic background in terms of nomenclature, in the course of 
which the stem cell concept was created and refined. In the end these two entities do have enough 
in common to share the same name, but they also have many differences. Here I shall look briefly at 
the history of these two traditions and then enquire how well various methods used today measure 
up in terms of detecting stem cells. Finally I shall review evidence indicating that stem cells do not 
exist outside their environmental context and that stem cell behavior is an emergent property of a 
multicellular system rather than of a single cell. 
Formulation of stem cell concepts 
Early uses of the term "stem cell" are reviewed by Maehle 2. The German equivalent, 
Stammzelle, was first used by Haekel in an evolutionary sense to represent the most primitive 
unicellular organisms from which all others had evolved. Later he applied the term to the fertilized 
egg, as the cell of origin of all cells in a single organism. Boveri later applied the term to the cell 
lineage in the nematode Ascaris, that underwent repeated divisions generating offspring of different 
fate before becoming the germ line. Following these early works, the term "stem cell" is barely 
mentioned in the first half of the twentieth century. Wilson, following Boveri, uses it to indicate the 
cells of nematode embryos undergoing reiterated divisions before becoming the germ line (Fig.2). 
However, "stem cell" does not figure in most embryological monographs written up to 1980, for 
example those by Spemann, Kumé and Dan, or Davidson 3-5.  One exception is the development of 
the leech. Here a number of cells called teloblasts undergo repeated divisions to generate 
segmentally reiterated progenitors and these were sometimes called stem cells 6. In conclusion, the 
embryological tradition made little use of the term stem cell, and where it was used it was 
associated most clearly with reiterated division to produce more committed descendants. 
The historical background to embryonic stem cells is reviewed by Solter 7. It arises more from 
cancer biology than from direct studies on embryos. Tumors called teratomas or teratocarcinomas 
had been known since antiquity and were unusual in containing a variety of structures and tissue 
types 8. They often occur in the gonads and by the early 20th century they were considered to be 
formed from germ cells by a deranged version of embryonic development. In 1954 Stevens 
discovered that mice of strain 129 spontaneously developed testicular teratomas, albeit at low 
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frequency. The tumors could be transplanted to other immunocompatible mice, and could be 
cultivated in vitro. Subsequently it was found that the LT strain showed an elevated number of 
ovarian teratomas. The embryonic nature of these tumors became well established when it was 
found that they could be initiated by transplanting fetal genital ridges or whole mouse embryos to 
extragonadal sites. Cell lines grown in vitro from the tumors became known as teratocarcinoma or 
embryonal carcinoma (EC) cells. A single cell from a teratoma transplanted to a new host could 
initiate another tumor contained a wide range of structures and tissue types 9. Even in the 1950s, 
the idea of cancer stem cells existed 10 and the initiating cells of the teratomas were sometimes 
called stem cells, although were more usually referred to as embryonal carcinoma (EC) cells.  It was 
found that in rare cases, EC cells could become integrated into early stage embryos of mice and that 
the cells were able to contribute to multiple tissues of the resulting adult mouse 11. It was thus 
apparent that the EC cells were pluripotent and that their malignant quality could, at least on 
occasion, be suppressed by the environment of the early embryo.   
An important technical advance rendering the in vitro culture of EC cells much more 
reproducible was the introduction of feeder layers of irradiated fibroblasts which secreted factors 
supporting the growth of the EC cells. Using feeder cultures or conditioned medium the growth of 
pluripotent cells directly from mouse blastocysts was achieved by Evans and Kaufman and, 
independently, by Martin 12, 13. These cells were able to grow without limit in culture. They could 
differentiate into embryoid bodies in vitro, and could form teratomas when grafted into 
immunocompatible animals. They could participate in mouse embryo development when injected 
into blastocysts, and even generate germ line chimeras capable of producing mice in the next 
generation, carrying the genes of the ES cells 14.  In the original papers Evans and Kaufman did not 
use the term stem cell although Martin did. The cells they discovered, or rather created, became 
generally known as embryonic stem (ES) cells. In this case the principal characteristic underlying the 
name is the pluripotent behavior of the cells. 
The most robust lineage of the concept of stem cell resides in the literature on hematopoiesis 
(formerly spelled hemopoiesis). The idea that all cells of the blood derived from a single type of cell 
in the bone marrow is usually attributed to the Russian histologist Maximow (also spelled Maximov 
or Maksimov) 15 although the German hematologist Pappenheim may have been the first to call this 
hypothetical cell type a Stammzelle 2. The term "stem cell" was often used thereafter in works on 
hematology and histology to indicate blood precursor cells in the bone marrow 16, 17. In the mid-
twentieth century interest in the stem cell concept re-emerged in the context of radiation biology 
combined with the study of hematopoiesis. According to Maximow's unitary theory, all blood cells 
(myeloid and lymphoid) arose from a common precursor, later called the 'hemocytoblast" and then 
the "hematopoietic stem cell" (HSC). But this theory was not universally accepted and until recent 
decades many considered that lymphoid cells had a different origin. Since the evidence at the time 
depended simply on histological study of normal marrow or on observations of hematopoiesis in 
various pathological situations, it was not possible to distinguish between the unitary and other 
theories. This had to await the development of techniques for the genetic marking of cells in vivo. 
It had been discovered during wartime research on atomic weapons that a graft of bone 
marrow could rescue irradiated animals from otherwise certain death. In 1956 it was shown using 
visible chromosome markers that the active ingredient of the marrow was cells, rather than some 
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sort of hormone 18. In 1961 Till & McCulloch found colonies of hematopoietic cells in the spleens of 
lethally irradiated mice that had received bone marrow grafts 19. These colonies contained erythroid, 
granuloid and megakaryoid cells and it was soon shown that they could generate further colonies on 
retransplantation into another irradiated host. The colonies were found to be clones using 
chromosomal markers 20. In the original paper the authors do not themselves mention stem cells, 
and cautiously call the initiating cells "colony forming units-spleen" (CFU-S). However from the time 
of their discovery the CFU-S were generally considered to be hematopoietic stem cells. Later it 
became apparent that they were what we should now call multipotent progenitors rather than true 
stem cells, for two reasons: first they do lose potency on retransplantation considerably faster than 
normal marrow 21, 22; secondly they did not form lymphocytes and by this time it was becoming 
accepted that the "true" endogenous HSC generated lymphoid as well as myeloid cells 23. 
An influential paper by Cairns 24 assumed that stem cells persist for the entire life of the 
organism and investigated the mechanism whereby such long lived cells might evade or reduce the 
number of somatic mutations that could initiate cancers. Lajtha (pronounced "Loitha") 25 
summarized the state of affairs as perceived by radiation biologists/hematopoiesis 
specialists/leukemia specialists and came up with the conclusion that hematopoietic stem cells 
survive at least as long as the whole organism, and that they are slower dividing than their progeny 
(the transit-amplifying cells). At about the same time Schofield 26 proposed that the true stem cells 
occupied a fixed number of niches in the bone marrow and that the immediate progeny of a stem 
cell could remain a stem cell so long as it occupied a niche. By 1983, Potten could edit a 
comprehensive collection of reviews which extended the stem cell concept from hematology to 
embrace also comparable cells in epithelial tissues, tumors, and lower organisms 27. The first chapter 
is by Lajtha recapitulating his earlier paper and this volume does mark the point at which the 
definition of stem cells had acquired its modern form. Although this volume is still useful today, a 
surprising absence from it is the embryonic stem cell, indicating that this tradition had yet to 
impinge on the world of the radiation biologists. 
During the historic development of the stem cell concept, the terms totipotency, pluripotency 
and multipotency were extensively used, sometimes without much discrimination. But they have 
now acquired different meanings from one another 28. There is a reasonable consensus that 
"totipotent" means able to form any cell in the body plus the trophectoderm of the placenta. 
"Pluripotent" means able to form any cell in the body. "Multipotent" means able to form more than 
one cell type. According to these definitions, the only totipotent cell type is the fertilized egg 
itselfand its early cleavage products, while pluripotent stem cells comprise the ES and iPS cells. The 
stem cells in the adult body that maintain tissue turnover are normally multipotent although there is 
one notable exception in the shape of the spermatogonia of the testis, which can produce only 
sperm.  
 Modern definition of stem cell 
Different individuals may cling to different usages of words, but the modern definition of stem 
cells is very much that set out by Lajtha 25. This commands a reasonable consensus 1, 29-31 although 
not everybody may agree with all aspects. Although derived from the hematological tradition, it 
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effectively embraces also the ideas from embryological tradition featuring reiterated divisions, and 
from the ES cell tradition emphasizing pluripotency. 
 Stem cells reproduce themselves. 
 Stem cells generate progeny destined to differentiate into functional cell types. 
 Stem cells persist for a long time. 
 Stem cell behavior is regulated by the immediate environment (the niche) 
This is shown diagrammatically in Fig.3. The first two items on the list indicate the key abilities of 
self-renewal and the generation of differentiated progeny. "Destined to differentiate" means that 
cell division may continue for a while before differentiation, but not indefinitely. Cells that 
proliferate for a limited number of cycles before differentiation are called progenitor cells or transit 
amplifying cells. The third item on the list means that if the stem cell population is one of those that 
exist in tissue culture then it should be capable of indefinite growth; while if it is part of an organism 
it should be very long lasting, normally persisting for the whole life of the organism. It is this criterion 
of indefinite lifespan that really distinguishes stem cells from progenitor cells. The fourth 
characteristic indicates that all stem cells exist in a specific micro-environment that controls their 
program of division and differentiation. This may seem at first sight only to apply to stem cells within 
the body and not to those grown in vitro, but, in order to get them to grow, the cells in vitro are 
always provided with specialized medium ingredients that, in effect, mimic the components 
normally provided in the niche. It is important to note that this definition involves not just intrinsic 
properties of stem cells but also properties that depend on aspects of their environment such as the 
lifespan of the animal, the nature of the niche, or the composition of the culture medium.  So to 
understand stem cell behavior, the characteristics of the environment are just as important as the 
intrinsic properties of the stem cells themselves.  
The above definition is of value in indicating the special characteristics of stem cell behavior, 
but is also helpful in indicating what is not stem cell behavior. The overall classification of cell 
behavior in terms of proliferation is due to the long term work of Leblond based on studies of 
mitoses and of radiolabeling with tritiated thymidine 32, 33. Leblond showed that some cell types, 
which he called "static", are completely postmitotic. They include multinucleate muscle fibers and 
neurons which are mostly formed in embryonic life and do not divide thereafter. Some cell types, 
which he called "expanding", continue to divide in the postnatal growth period and during adult life 
they may divide occasionally and are able to repair damage. The "expanding" types comprise 
connective tissues and many epithelial tissues including the liver, kidney and pancreas. Finally there 
are the renewal tissues in which there is continuous cell production and loss throughout life, fed by a 
population of stem cells. Renewal tissues include the epidermis, intestinal epithelium, hematopoietic 
system and spermatogonia. Evidently the cells classified by Leblond as static or expanding are not 
stem cells. But the fact that a specific cell type is not a stem cell does not mean that there are no 
stem cells in the tissue to which this cell type belongs. For example, there are some neural stem cells 
in some parts of the CNS 34, and there are numerous satellite cells in the skeletal muscle which can 
form new muscle fibers following damage 35. However, several recent studies have confirmed the 
lack of stem cells in the normal liver or pancreas 36, 37. 
A rather surprising consequence of adopting the consensus definition of stem cells is that the 
cells of the early mammalian embryo that are the precursors of ES cells, namely the cells of the inner 
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cell mass and the epiblast, are not themselves stem cells. This is because their pluripotency is very 
short lived and they become committed to various pathways of differentiation within 1-2 days. The 
definition indicates that stem cells, with their indefinite lifespan, may arise from progenitor cells, 
which have a finite lifespan in a particular state of commitment. The origin of stem cell populations 
from progenitor cells does occur repeatedly in normal development with respect to the formation of 
the various types of tissue-specific stem cell.  
Despite the reasonable consensus underpinning the definition presented here, a common 
term still found in the literature is "stem/progenitor cell".  This is a singularly unhelpful designation 
as it conflates two entirely different cell behaviors, and it would be best avoided.  
Types of stem cell 
So what cell types do correspond to stem cells under this definition? As indicated above, real 
stem cells comprise two fundamentally different types: the pluripotent stem cells that exist only in 
vitro, and tissue-specific stem cells that exist in vivo in the postnatal organism.  
Pluripotent stem cells comprise embryonic stem cells (ESC) and induced pluripotent stem cells 
(iPSC) (Fig.4). ES cells are cultivated from the inner cell mass of early embryos. A subclass consists of 
the SCNT lines where the embryo was created by somatic cell nuclear transfer(SCNT) into an oocyte 
and the resulting embryos are used to establish the cell lines 38. iPS cells are created by expressing 
key pluripotency-associated transcription factors in differentiated cell types such as fibroblasts, 
leukocytes or epithelial cells 39, 40. The best quality iPS cell lines are very similar to ES cells and the 
best mouse lines can form germ line chimeras when injected in mouse blastocysts, and can even 
form a complete mouse embryo using the technique of tetraploid complementation 41, 42. Genomic 
analysis of human pluripotent cell lines shows that the SCNT-derived cells are close to ES cells in 
epigenetic status while iPS cells may diverge more 43.  
Pluripotent stem cells may exist in one of two distinct states named "naive" and "primed" 
corresponding roughly respectively to cells of the early epiblastinner cell mass or of the egg cylinder 
epiblast of mouse embryos 44. Naive cells have both X-chromosomes active in females, can form 
chimeras in mouse blastocysts, and maintain pluripotency in response to leukemia inhibitory factor 
(LIF). Primed cells have undergone X-inactivation, do not form chimeras, and maintain pluripotency 
in response to fibroblast growth factor (FGF). Both types also share a number of properties: they can 
be propagated without limit in vitro, and, under appropriate culture conditions, they are able to give 
rise to a wide variety of cell types, perhaps all the cell types in the normal organism except for the 
trophectoderm of the placenta. Both will form embryoid bodies in vitro and establish teratomas 
when grafted to immunocompatible hosts. 
The other principal class of stem cell comprises the tissue-specific stem cell populations which 
exist within the adult body and generate progeny to repopulate the tissue in question. Well studied 
examples include those of the hematopoietic system, the epidermis, the intestinal epithelium and 
the spermatogonia of the testis. Under normal circumstances, tissue specific stem cells do not 
produce cells characteristic of other tissue types. All types of tissue specific stem cell reside within a 
niche, which provides an environment suitable for continued function of the stem cells. This often, 
but not always, secretes Wnt factors to maintain stem cell proliferation 45.  
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There are also some types of stem cell that do not undergo continuous division, but seem to 
be kept in reserve to deal with tissue regeneration when required. A good example is the muscle 
satellite cell, which is normally quiescent but able to be mobilized to divide and fuse to form new 
myofibers following injury 35. A more contentious example is the periportal cell of the liver that may, 
under experimental circumstances where hepatocyte division is prevented, generate new 
hepatocytes to repopulate the liver 46. This type of stem cell behavior is sometimes called facultative. 
By definition, stem cells must produce differentiated progeny, but how many differentiated 
cell types does each sort of stem cell actually produce? The answer is very variable and depends on 
the tissue concerned. In the intestine, stem cells produce absorptive, goblet, tuft and Paneth cells, 
together with several types of enteroendocrine cells. In the bone marrow, the hematopoietic stem 
cells produce all the cell types of the blood and immune system. At the other end of the scale, the 
spermatogonia of the testis produce only sperm. Epidermal stem cells are often said to produce only 
keratinocytes, but they can also form a type of neuroendocrine cell called the Merkel cell, 
responsible for touch sensitivity. The examples of both the intestine and the epidermis indicate that 
neuroendocrine cells can arise from epithelial stem cells which are quite separate from the central 
or peripheral nervous systems. But the formation of neuroendocrine cells in these tissues is not 
indicative of a wider potency of stem cells enabling cell types of other tissue to be formed. 
Stem cell markers 
How can you discover whether a cell is a stem cell? Or, more accurately, how can you tell if a 
cell exhibits stem cell behavior? Early attempts using RNA profiling to discover a "stemness" 
signature characteristic of all stem cells proved unsuccessful 30, 47, 48. However, very often a cell is said 
to be a stem cell because it expresses one or more specific gene products associated with stem cells. 
In fact, there is no molecular marker that identifies all stem cells and excludes all non-stem cells. 
Those components required for general cell metabolism and cell division are certainly found in all 
stem cells, but they are also found in many other cell populations as well.  
Pluripotent stem cells (ESC and iPSC) express an important network of transcription factors 
which are necessary for maintenance of the pluripotent state 49. A key member of the pluripotency 
group is the POU-domain transcription factor OCT4 (also known as OCT3 and POU5F1). The presence 
of OCT4 is certainly necessary for the properties of pluripotent stem cells. However, conditional 
knockout of the Oct4 gene indicates that it is not required for the maintenance of any tissue specific 
stem cell population in the mouse 50. So OCT4 cannot be considered to be a general stem cell 
marker. Claims of discovery of OCT4-expressing cells in mouse or human, other than germ cells, have 
been made, but are complicated by the existence of cross-reacting antigens and pseudogenes 51. 
Telomerase 
A component that might be expected to be found in all stem cells is the telomerase complex 
52. At the end of each chromosome is a structure called the telomere, made up in vertebrate animals 
of many repeats of the simple sequence TTAGGG. Because of the nature of DNA replication, the 
double helix cannot be copied right up to the end, so a part of the telomere is lost in each cell cycle. 
After enough cycles, the erosion of the chromosome ends activates a system which senses DNA 
double stranded breaks and causes death of the cell. This process is an important reason for the 
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limited survival time of most primary tissue culture cell lines, which undergo senescence after a 
certain number of population doublings in vitro. Obviously there must be a mechanism for repairing 
telomeres in vivo, and this is provided by the telomerase  complex, of which the most important 
components are an RNA-dependent DNA polymerase called TERT, and an RNA called TERC which 
contains the template CCCTAA for the telomere sequence in the DNA 53. High levels of telomerase 
are found in germ cells, ensuring the survival of full length chromosomes for the next generation. 
Telomerase is also upregulated in permanent (“transformed”) tissue culture cell lines and in most 
cancers. However most types of somatic cell have little or no telomerase. Tissue specific stem cells 
do contain some telomerase; generally enough to maintain cell division for a normal lifetime, but 
not enough to fully reverse the erosion of the telomeres. In situations such as repeated 
transplantation of hematopoietic stem cells from one mouse to another there is an upper limit to 
the number of possible transplants and this is determined at least partly by telomere erosion 54. The 
presence of telomerase can be considered to be a stem cell marker, although it is not specific, being 
also found in permanent tissue culture lines, early embryos and most cancers.  
Other possible stem cell markers 
The cell surface glycoprotein CD34 is found on human hematopoietic stem cells (HSCs) and 
can be used to enrich them from bone marrow by fluorescence-activated cell sorting (FACS) 55. It has 
been considered by some to be a more general stem cell marker 56. However it is also found on non-
stem cell types, such as capillary endothelial cells, and it is unclear whether it is actually necessary 
for the stem cell behavior of the HSC. In fact, since it is not found on mouse HSC, which are generally 
similar in behavior to human HSC, it is probable that it is not necessary. CD34 is not found on human 
embryonic stem cells or on most epithelial stem cell types, indicating that it is not a generic stem cell 
marker.  
A molecular marker which is known to be required for stem cell function is LGR5 57. This is an 
accessory receptor for the Wnt family of signaling molecules and is found on stem cells in the 
intestine, hair follicle, mammary gland and stomach 58, 59. These types of stem cell all depend on Wnt 
signaling from their environment for continued cell division, so the presence of the LGR5 is really 
necessary. However it is not found on other types of stem cell so cannot be considered to be a 
universal marker.  
An interesting type of marker is that offered by dye exclusion, in particular exclusion of 
Hoechst 33342. This is a bisbenzimide dye, excited by UV light to emit a blue fluorescence. It is 
widely used as a DNA-binding reagent, but it is also actively pumped out of some cell types. If a 
subgroup of cells has lost more dye than the rest of the population then it appears in flow cytometry 
as a cluster of cells showing less blue fluorescence than average. This is called a side population 60. 
The side population is enriched for stem cells in some situations, especially in murine bone marrow 
where it provides a similar degree of enrichment of hematopoietic stem cells using fluorescence 
activated cell sorting (FACS) as does a suitable panel of cell surface markers 61.  The dye exclusion 
property is due to the activity of cell membrane transporter molecules including the P-Glycoprotein 
(MDR1) and transporters of the ABC class. Dye exclusion is indicative of an increased capacity for 
export of all hydrophobic small molecules, many of which are toxic to cells. Although useful to the 
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investigator, it is unlikely that this capacity is really important for stem cell behavior. For example, 
mouse embryonic stem cells show dye exclusion while human ones do not 62. 
In summary, there is probably no single gene product which is found in all stem cells and not 
in any non-stem cell. Many so-called stem cell markers are not necessary for stem cell behavior. Of 
those gene products which are necessary for stem cell behavior, some, such as the cell division 
machinery and telomerase, are found in stem cells and in some non-stem cells. Others, such as OCT4 
or LGR5, are found in some, but not all, types of stem cell. 
Label-retention 
In his article of 1979, Lajtha expressed the view that hematopoietic stem cells were slow 
dividing compared to their transit cell progeny 25. He considered that a long period between 
divisions would allow the cells to undergo full DNA repair and thus minimize the effects of somatic 
mutations which might otherwise cause cancer. Since then, it has become a widely held view that 
label retention is associated with stem cell character 63. 
The reason that label retention correlates with slow division is the following. When a cell 
population is exposed to a DNA precursor, such as the nucleoside bromodeoxyuridine (BrdU), which 
is metabolized by cells in the same way as thymidine, all cells undergoing DNA synthesis will 
incorporated it into their DNA and so become labeled 64. The BrdU in the cell nuclei can be detected 
by immunostaining. After the BrdU supply is withdrawn, so long as cell division is continuing, then 
the level of BrdU in the DNA will halve with every subsequent S phase and become undetectable to 
immunostaining after about 5-6 divisions. If a cell divides slower than average, it will retain 
detectable BrdU for longer. In Fig.5 is shown an image of a hematopoietic stem cell (HSC) visualized 
with an antibody to the cell surface marker CD150.  It retains a DNA precursor label (EdU) from a 
pulse given 30 days previously. Likewise, muscle satellite cells, cells of the hair follicle bulge and of 
the limbus of the eye are characteristically label retaining 65. This relatively quiescent behavior is 
considered necessary to maintain regenerative function of some types of stem cell over a lifetime. If 
the mechanisms of quiescence are disturbed in mice by knocking out key components, then 
hematopoietic stem cells or muscle satellite cell populations have been shown to become exhausted 
during the lifetime of the animal because they are dividing too much 63.   
However, label retention is by no means universal among stem cells. For example, it is not 
shown by intestinal or epidermal stem cells. It is also, of course, not shown by the pluripotent stem 
cells (ES or iPS cells) which undergo rapid division in culture. Moreover there are many other cell 
populations that divide slowly, especially differentiated cells that undergo occasional division.  So 
label retention cannot be considered as a universal stem cell marker. 
The niche 
The concept of a stem cell niche arose in the 1970s to explain the fact that the spleen colony-
forming cells from the bone marrow had a lesser differentiation potency than hematopoietic stem 
cells in vivo 26. The idea is that stem cells require continuous exposure to signals from surrounding 
cells in order to maintain their stem cell behavior. This was first proved experimentally by Spradling, 
using the fruit fly Drosophila 66, 67, 68. 
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In the Drosophila ovary there are germline stem cells (Fig.6). These lie in contact with somatic 
cells called cap cells, which secrete a TGF-like molecule called Decapentaplegic (Dpp). Dpp 
maintains the stem cells in mitosis. But as they divide, some of their progeny become displaced from 
contact with the cap cells, and are then exposed to less Dpp. The fall in Dpp signal lifts a repression 
on the oocyte maturation process and enables them to differentiate to cystoblasts. These undergo a 
fixed differentiation program, dividing four times to generate a post-mitotic complex of one oocyte 
and 15 supporting nurse cells. This illustrates the behavior of a niche very nicely. The stem cells 
continue to divide so long as they are in contact with the niche, and they differentiate when they are 
no longer in contact. If a stem cell is removed experimentally, its position may be taken by a 
cystoblast which would normally have differentiated, but because of its renewed occupancy of the 
niche it remains a dividing stem cell. 
In the Drosophila ovary there are female germ cells called cystoblasts (Fig.6). These lie in 
contact with somatic cells called cap cells, which secrete a TGF-like molecule called 
Decapentaplegic (Dpp). Dpp maintains the cystoblasts in mitosis. But as they divide, some of the 
cystoblast progeny become displaced from contact with the cap cells, and are then exposed to less 
Dpp. The fall in Dpp signal lifts a repression on the oocyte maturation process and enables the 
cystoblast to differentiate. It then undergoes a fixed differentiation program, dividing four times to 
generate a post-mitotic complex of one oocyte and 15 supporting nurse cells. This illustrates the 
behavior of a niche very nicely. The cystoblasts continue to divide so long as they are in contact with 
the niche, and they differentiate when they are no longer in contact. If a cystoblast is removed 
experimentally, its position may be taken by a progeny cell which would normally have 
differentiated, but because of its renewed occupancy of the niche it remains a dividing cystoblast. 
Probably all the stem cells types in the mammalian body exist within specific niches like this 
which control their behavior.  For example the intestinal stem cells lie adjacent to Paneth cells which 
supply WNT 69, and spermatogonial stem cells lie adjacent to Sertoli cells that supply them with Glial 
Derived Neurotrophic Factor (GDNF) 70. In both cases the signaling molecules are needed to maintain 
the stem cells in mitosis, and removal from the niche brings an end to cell division unless the factors 
are provided experimentally. In the bone marrow, there has been considerable controversy about 
the exact nature of the niche 71, but hematopoietic stem cells are often found adjacent to blood 
vessels, as shown in Fig.5. The WNT signaling system is needed for continued function of a variety of 
stem cells: at least those of the intestine, stomach, epidermis, hair follicles and mammary gland 45. 
But it is probably not possible to say that "niche=WNT" as there are clearly other factors also at work 
and the role of WNT in relation to the HSC and spermatogonial stem cells is still unclear. 
Transplantation and in vitro culture 
Should transplantability be part of the definition of the stem cell? Perhaps surprisingly, since 
transplantation has been so important to work on the hematopoietic stem cell, it did not form part 
of the definition of Lajtha 25. There are two major difficulties with the idea. First, cells may be 
transplanted to immunocompatible hosts, and continue to function, even when they are not stem 
cells. Examples are grafts of hepatocytes 72 or of islet cells 73, but there are many others. Secondly, 
the nature of cells may change on transplantation because there are the stresses of dissociation, 
isolation and injection, followed by effects of the host environment. In hematopoietic 
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transplantations, hosts are usually heavily irradiated or treated with cytotoxic drugs, and this can 
also have effects on cell behavior. It is becoming clear that the behavior of HSC following 
transplantation is not the same as in undisturbed homeostatic hematopoiesis 74. Following 
transplantation only a few HSC clones dominate the regenerated blood, whereas in normal 
homeostasis the number of clones is much larger, and the survival time of some multipotent 
progenitors is much longer.  
A type of stem cell defined almost entirely by transplantation is the so-called cancer stem cell. 
These are subsets of cells from tumors, isolated using various stem cell markers, which will generate 
tumors in immunodeficient hosts following grafting, under conditions where the majority of cells 
from the same tumor do not. The concept of cancer stem cells has been around for many decades 9, 
10 although it has been recently revived in popularity. Some cancers certainly do contain stem cells, 
like their parent tissues 75. But others do not 76, and some doubt has been cast on the usefulness of 
the concept by the non-specificity of many of the markers used for cancer stem cell isolation, and by 
the strong effects of the host genetic constitution on which cells will or will not successfully 
transplant 77. 
Cell properties can change on transplantation but they can do so even more drastically during 
in vitro culture. Tissue culture media are normally formulated to achieve rapid cell growth, whereas 
most cells in vivo are slowly dividing or quiescent. For this reason it is not surprising that cells 
showing stem cell behavior may be grown in culture even when their in vivo progenitors did not 
show stem cell behavior. The most obvious example is the embryonic stem cell itself. In vitro, ES 
cells are stem cells as they can proliferate without limit, and can generate a wide range of 
differentiated progeny. But in vivo the parent cells rapidly acquire more specialized forms of 
commitment, depending on the morphogen gradients present in the early embryo. There are other 
examples. For example, neurospheres are small cell clumps that grow in suspension. They contain 
both undifferentiated cells together with neurons and glia. When dissociated and replated, a small 
proportion of the cells generate new neurospheres. Although there are some real neural stem cells 
in the mammalian brain 34, neurospheres can be cultivated from any part of the CNS, whether it 
contains stem cells or not 78.  
There are numerous cell lines described as "stem cells" that have very uncertain connections 
to real stem cells in vivo. Most notably there are the "stem cells" which are now marketed for 
human therapy by various companies 79. Many of these are mesenchymal stem cells (MSCs). MSCs 
do exist in the bone marrow and are probably precursors of bone 80. The in vitro cell lines are often 
supposed to have wide plasticity and to be able to form many cell types after transplantation. 
However, following a vogue for such reports around the year 2000 it is now considered that such 
abilities were seriously overstated 81 and that any beneficial effects they might have following 
transplantation are due to effects on inflammation, angiogenesis and immune modulation 82. Most 
would not be considered stem cells by the criteria used here. 
In vivo lineage labeling 
Without doubt the most reliable method for establishing the existence of stem cell behavior in 
vivo is genetic lineage labeling. This was pioneered in Drosophila. An early study of the ovary with 
genetic mosaics showed that there must be more than one germ line stem cell in each ovariole 83. 
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Later, using the FRT system with a heat shock to induce labeled clones, Margolis and Spradling found 
that both germ line and follicle cell clones were labeled 84.  This work showed that a label in a stem 
cell would persist indefinitely and that each ovariole contained 2-3 germ cell stem cells and about 2 
somatic stem cells. In the mouse  using the CreER system has been the most widely used for stem 
cell labeling 85, 86. So far it has only been widely used in mice, but tThe availability of CRISPR-Cas9 
technology will soon make it available for other organisms as well as the mouse. The principle is to 
use a DNA recombinase enzyme (Cre) to impart a permanent genetic label to a cell type in vivo that 
has a particular promoter highly active. The label is subsequently heritable on cell division and is 
unaffected by any differentiation events occurring in the progeny cells. A modification of the Cre 
recombinase (CreER) which is activatable by estrogen-like hormones enables the labeling to be 
initiated at a specific time. A low dose of tamoxifen causes the labeling of just a few cells, and if their 
progeny remain well separated this can enable clonal analysis in vivo. Once it has been labeled, a 
stem cell will produce a sector of labeled tissue in which all its dividing and differentiated progeny 
carry the label. The labeled sector will grow initially as cells divide and mature and will eventually 
reach a steady state in which addition of new labelled cells is balanced by the removal of dead ones. 
This pattern should then remain unchanged in the long term. By contrast, labeling a transit 
amplifying cell will produce only a transient patch of labeled cells which will disappear as they 
mature and die. Examples from the intestine and from the epidermis are shown in Figs.7 and 8. This 
method has been used to visualize stem cells in the intestine, stomach, epidermis, hair follicle, 
mammary gland and testis. It is, of course, dependent on the specificity of the promoter used to 
drive expression of the CreER gene and great care needs to be taken to characterize this fully. 
 It is often thought that all stem cells must undergo asymmetric divisions, with one daughter 
being a stem cell and the other destined to differentiate 87. This does sometimes occur, but it is also 
common for stem cells to have a less rigid program of cell division with some divisions producing 
two stem cells, some two progenitor cells, and some producing one of each. This is called the 
stochastic model 88. Maintenance of a steady state requires that the stem cell number remains 
constant, although there may be occasions where it needs expanding, such as during normal growth 
of the organism or following injury. Study of the early divisions following lineage labeling in both the 
intestine 89 and the epidermis 90 and testis 91 have indicated that they do follow the stochastic rather 
than the obligatory asymmetric type of division.  
 The stochastic model gives different predictions from the obligate asymmetric division 
model about the nature of the labeled stem cell clones visualized by the CreER system. In the 
situation of the obligatory asymmetric division, labeled stem cell clones each comprise one stem cell 
plus all their descendants. When the steady state has been reached, the labeled clones should 
persist for life and stay the same size. However in the stochastic model, clones may be lost if their 
stem cell divides to form two transit amplifying cells. They may also increase in size if their stem cell 
divides to form two stem cells. This situation has been modeled mathematically and it predicts that 
the number of labeled clones should steadily decline with time while the size of clones should 
become progressively more disparate, with the average size increasing. This means that the 
proportion of the tissue occupied by the labeled clones remains roughly constant but the number of 
labeled clones becomes progressively fewer and their size more varied (Fig.8). This behavior is 
precisely what is observed when lineage labeling data are analyzed quantitatively, at least for the 
epidermis, spermatogonia and intestinal epithelium. In particular there is a property called “scaling 
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behavior” which means that the frequency distribution of labeled clone sizes, divided by the average 
clone size, stays the same over time. Under such circumstances, which may turn out to be the norm 
for mammalian stem cell systems, the key stem cell properties of self-renewal, persistence and 
differentiation are still maintained, but they exist at a cell population level rather than as the 
properties of a single cell. If the stochastic model is indeed correct, it does imply the existence of 
some mechanism that can control the number of stem cells and prevent them from either dying out 
or growing like a tumor to overwhelm the organism. This might be a property of the niche, as in the 
Drosophila ovary where, ifstem cells move too far from the source of Dpp, they become 
differentiating cystoblasts. Alternatively there might be some kind of density-dependent control 
exterted by the stem cells themselves. In any case this is a topic for future research. 
Conclusion 
The above discussion indicates that stem cells carry no universal molecular marker, that they 
are not all quiescent, that they are not necessarily the same as transplantable cells, and even that 
they may not be definable at the individual cell level at all but only at a population level. None of this 
should be a surprise. Various other authors who have examined the concept have also concluded 
that stem cell behavior is a system property of a tissue, not a property of individual cells 30, 31, 48, 92.  
Of course, what is considered to be a stem cell or not to be a stem cell all depends on the 
definition employed. The definition given here comprises four properties which do make up a 
consensus view of stem cells acceptable to most scientists today. However, some will disagree with 
one or another element of the set. It is always possible to change the definition and thereby change 
what counts as a stem cell and what does not. For example, there are some cells at the periphery of 
the developing mammalian kidney that are sometimes called stem cells because they reproduce 
themselves and generate new kidney tubules 93. But these cells only persist for a few cell cycles 
during fetal development so do not satisfy the third criterion given here. They could be counted as 
stem cells only if this property were abandoned. As another example, some will insist that a stem 
cell must be able to give rise to more than one type of differentiated progeny, in which case the 
spermatogonia have to be removed from the list of tissue specific stem cells since they produce only 
one type of differentiated cell: the sperm. 
 Perhaps because of the high profile of stem cell research generally, some attention has been 
given to the stem cell concept by philosophers of science. In a recent book, Laplane considers the 
various proposed attributes of stem cells and classifies these as categorical, dispositional, relational 
and system-based. A categorical property is essential and intrinsic, for example the presence of 
OCT4 in pluripotent stem cells. A dispositional property is a property revealed under particular 
conditions. For example intestinal stem cells need a Wnt signal from their niche in order to 
proliferate, so this property depends not just on the nature of the stem cell, but also on something 
else. A relational property is said to exist if it depends entirely on something else: for instance a 
hypothetical niche which would make any cell whatever that occupied it into a stem cell. Finally a 
systemic property belongs, in this context, not to individual cells but to the whole system, for 
example a tumor in which cells might acquire or lose stem cell behavior in specific circumstances. 
Laplane concludes that stem cells do comprise a "natural kind" (i.e. a real thing, out there, not just a 
figment of our imagination), but that they require a complex definition with a general part "stem 
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cells are the cells from which tissues are developed and maintained", and a set of specific parts 
which in effect list the various properties discussed above. Apparently philosophers will accept that 
a natural kind may be defined by a set of attributes which are both categorical and dispositional, and 
of which not all need apply in every instance. 
Debates such as these may cause momentary panic: how can something as familiar as the 
stem cell become so intangible when examined critically? The contribution of philosophers may be 
considered negative if it just makes familiar entities disappear. However the philosophical view is 
worthwhile if it makes us examine the concepts critically. In the case of stem cell biology what 
emerges from a critical evaluation is that we should think not about stem cells as such but about 
stem-type behaviors that may be shown by various cell populations in specific circumstances. 
Defining stem cells is slippery and difficult, but defining stem cell behavior is relatively easy. In order 
to manipulate it in practical situations we need to understand the complete context.  
In the popular media and even in some medical circles, stem cells are presented as miracle 
cells that can do anything. When administered to a patient with some serious disease they will 
rebuild the damaged tissues and make the patient young again. Alas, in reality there are no such 
cells. But there are certainly cells that exhibit stem cell behavior and the future of regenerative 
medicine will undoubtedly be built on a good scientific understanding of their properties.  
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Figures 
Figure 1. Mentions of "stem cell" in the abstracts of all papers in the Web of Science Core Collection. 
The totals are shown in 5 yearly intervals and rise from 372 in 1977-82 to 71545 in 2012-16. 
Figure 2. A portion of Fig. 135 from "The Cell in Development and Heredity" by E.B.Wilson (1925). 
This shows the term "stem cell" being used to describe early divisions of embryo blastomeres 
leading to the germ line. 
Figure 3. A consensus diagram showing stem cell behavior.  The stem cell exists in a specific niche 
which enables it to undergo self-renewing divisions. It also generates a variety of differentiated cells 
via a population of committed but still dividing transit-amplifying cells. Not all stem cell types 
generate multiple types of differentiated cell. 
Figure 4. Different kinds of pluripotent stem cells. (a). Mouse ESC. (b). Mouse iPSC. (c). Human iPSC 
induced to a naive pluripotent state with chemical inhibitors. (d). Human ESC. (e). Human iPSC. (f ). 
Mouse EpiSC. Note the flatter colony morphology for (d)–(f ). (From: Robinton, D.A. and Daley, G.Q. 
(2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295–305. 
Reproduced with the permission of Nature Publishing Group.) 
Figure 5.  Hematopoietic stem cell, identified by staining with an antibody to CD150 (red), and also 
labeled with EdU (white) from a pulse given 30 days previously. The green color shows pericytes 
expressing nestin‐GFP surrounding a small arteriole. (Kunisaki, Y., et al. (2013) Arteriolar niches 
maintain haematopoietic stem cell quiescence. Nature 502, 637–643. Reproduced with the 
permission of Nature Publishing Group.) 
Figure 6. The stem cell niche in the Drosophila ovary. Cystoblasts are fFemale germ cell stem cells 
that require continued contact with cap cells to remain stem cells. Once they lose contact with cap 
cells they differentiate into a cyst of one oocyte and 15 nurse cells. 
Figure 7. Descendants of stem cells in the mouse intestine visualized by the CreER method. The stem 
cells express a protein, LGR5 whose promoter is used for labeling. (a). The mice were labeled 1 day 
previously, in (b) 5 days previously, and in (c) 60 days previously. The initial label is in the LGR5 
positive cells themselves (arrows); subsequently, ribbons of descendant cells up the crypts and villi 
become labeled. (Originally from: Barker, N. et al. (2007) Identification of stem cells in small 
intestine and colon by marker gene Lgr5. Nature 449, 1003–1007. Reproduced with the permission 
of Nature Publishing Group. 
Figure 8. Lineage tracing of epidermal stem cells in mouse skin. The mice express Axin2‐CreER with 
an R26R type reporter expressing GFP (green) following Cre mediated recombination. The blue color 
is DAPI stain for cell nuclei, and the red is immunostaining for Dickkopf3, a Wnt inhibitor present in 
the superficial layers. Tamoxifen was given on postnatal day 21 and the images show the situation at 
1 day and 2 months thereafter. (a) 1 day, a few basal layer cells are labeled. (b) 2 months, clones of 
labeled cells are visible leading from the basal layer to the surface. (From: Lim, X., Tan, S.H., Koh, 
W.L.C., et al. (2013) Interfollicular epidermal stem cells self‐renew via autocrine Wnt signaling. 
Science 342, 1226–1230. American Association for the Advancement of Science.) 
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Figure 9. Stochastic stem cell model. (a) The four types of stem cell division, producing two, one or 
no daughter stem cells. (b) Disappearance of labeled clone, and doubling of size of labeled clone. (c) 
Consequent tendency of labeled clones to become fewer but larger with time. 
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